Stock Events

Stock Events

Stoke Therapeutics (STOK) Q1 2025 Earnings

18MarConfirmed

Q2 2024

Q3 2024

Q4 2024

Q1 2025

-0.61

-0.47

-0.32

-0.18

Details

Expected EPS

-0.52817

Actual EPS

-0.18

Surprise EPS

0.35

Surprise Percent

+65.92%

Description

Stoke Therapeutics (STOK) has reported earnings of -0.18 per share for Q1 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.